Form 4: PRO DEX Director Raymond Cabillot Receives Restricted Stock
Insider Transaction Report
PRO DEX Director and 10% owner Raymond E. Cabillot was granted 1,000 restricted shares under the company's 2016 Equity Incentive Plan.
Summary
- Raymond E. Cabillot, a Director and 10% owner of PRO DEX INC (PDEX), acquired 1,000 shares of common stock.
- The acquisition occurred on November 20, 2025, and was a grant of restricted shares under the Issuer's 2016 Equity Incentive Plan.
- The shares were acquired at a price of $0.00, indicating they were part of an equity compensation award.
- Following this transaction, Cabillot directly beneficially owns 2,000 shares of common stock.
- Additionally, Cabillot indirectly beneficially owns 270,846 shares through Farnam Street Partners, L.P.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. It's a routine insider transaction (equity grant) which generally aligns management interests with shareholders, but it doesn't provide new operational or financial performance information.
Positives
- The grant of restricted shares to a director and significant owner aligns management's interests with shareholders.
- The transaction was executed under a Rule 10b5-1(c) plan, demonstrating a pre-planned and transparent approach to equity compensation.
Future Outlook
This filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on an insider transaction.
Industry Context
This Form 4 filing is a routine disclosure of an insider's equity transaction and does not provide broader industry context. Equity grants to directors are a common practice in publicly traded companies to align leadership incentives with shareholder value.
Comparison to Industry Standards
- The grant of restricted shares to a director is a standard practice in corporate compensation across various industries, including medical device manufacturing where PRO DEX operates.
- The use of a Rule 10b5-1 plan for such transactions is also a common and recommended practice for insiders to avoid accusations of trading on material non-public information, aligning with best practices for corporate governance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Utilization | Grant of restricted shares under the Issuer's 2016 Equity Incentive Plan to a director. | 11/20/2025 | Reinforces alignment of director's interests with long-term shareholder value through equity compensation. |
Stakeholder Impact
- Shareholders: The grant of restricted shares to a director and 10% owner can be viewed positively as it aligns management's long-term interests with shareholder value creation.
Key Dates
| Date | Description |
|---|---|
| 11/20/2025 | Date of transaction for the acquisition of common stock. |
| 11/21/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing reports a routine insider transaction involving an equity grant to a director. While it indicates continued alignment of management's interests with shareholders, it does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.
Keywords
PRO DEX, PDEX, Raymond Cabillot, Restricted Stock, Equity Incentive Plan, Form 4, Insider Ownership, Corporate Governance, Stock Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.